In a recent development regarding COVID-19 vaccine, the Centre has taken a call to not extend indemnity to vaccine developing companies who have got emergency use authorisation for their Covaxin and Covishield” jabs.
The two major firms involved in manufacture of COVID-19 vaccinatiom, Bharat Biotech International Limited and Serum Institute of India will be liable to pay damages.
The purchase agreement says that the company shall be liable for all adversaries as per CDSCO Drugs and Cosmetics Act/ DCGI Policy/approval. “Companies also have to inform the government in case of serious adverse advents,” reads the contract of BBIL. The purchase agreement has spelt this out clearly.
